Serostim Investigation Leads To Indictment Of Four Former Serono Execs
This article was originally published in The Pink Sheet Daily
Executive Summary
Boston U.S. Attorney's office announces indictments by a federal grand jury against two former Serono VPs and two former regional sales directors. The indictment alleges the execs conspired to offer physicians all-expenses paid trips to a meeting in Cannes, France in exchange for writing Serostim prescriptions.
You may also be interested in...
Serono Labs Pleads Guilty To Criminal Conspiracy Charges In Serostim Case
Serono Inc., which reached a $704 mil. settlement with federal and state prosecutors, says its brand products will remain available under federal healthcare programs despite the guilty plea by its U.S. affiliate.
Serono Labs Pleads Guilty To Criminal Conspiracy Charges In Serostim Case
Serono Inc., which reached a $704 mil. settlement with federal and state prosecutors, says its brand products will remain available under federal healthcare programs despite the guilty plea by its U.S. affiliate.
Serostim Sales Plan Included Physician Kickbacks, Government Alleges
A former Serono regional sales manager is charged in Boston federal court with offering kickbacks for prescribing Serostim in 1999. The Boston U.S. Attorney alleges that a Serostim sales plan “required” regional directors to target high-prescribers of the AIDS wasting treatment with “financial incentives.”